FDA Seeks Comments on Foreign Food Safety Verification Rules
Published Date: 5/1/2025
Notice
Summary
The FDA wants your thoughts on how importers check that food from other countries is safe for people and animals. This update affects importers who must keep good records and follow new rules to keep food safe. You’ve got 60 days to share your ideas before the FDA finalizes the paperwork, which helps keep food safe without costing too much.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Importers Face FSVP Recordkeeping Burden
If you import food for humans or animals, the FDA is asking for public comment on its Foreign Supplier Verification Programs (FSVP) paperwork. Importers may need to keep records and follow new verification rules, and the FDA is soliciting comments for 60 days under the Paperwork Reduction Act.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20085, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Improvement Program
The FDA is asking for public feedback by November 2, 2026, on its Voluntary Improvement Program (VIP), which helps medical device makers improve quality through third-party reviews. This program supports better products and safer devices without adding extra costs or deadlines for companies. It’s all about encouraging excellence and teamwork between the FDA, industry, and partners like the Medical Device Innovation Consortium.
Previous / Next Documents
Previous: 2025-07591, Agency Information Collection Activities; Proposed Collection; Comment Request; Establishing and Maintaining Lists of United States Establishments With Interest in Exporting Human Food Program-Regulated Products
The FDA wants your thoughts on how they collect info about U.S. businesses interested in exporting human food products. They’re asking for comments over the next 60 days to make sure their paperwork isn’t too tricky or time-consuming. This helps keep export lists up-to-date without costing businesses extra time or money.
Next: 2025-07593, Agency Information Collection Activities; Proposed Collection; Comment Request; Export Notification and Recordkeeping Requirements
The FDA wants your thoughts on updating how companies report and keep records when exporting drugs, devices, food, cosmetics, and tobacco products. This affects businesses that send these products overseas and could change what info they need to share or save. You’ve got 60 days to speak up before any changes happen—so don’t miss your chance to weigh in!